Albendazole 400mg 3 chewable tablets

Composition
active ingredient: albendazole;

1 chewable tablet contains albendazole 400 mg;

excipients: corn starch, microcrystalline cellulose, sodium methylparaben (E 219), sodium propylparaben (E 217), sodium starch glycolate (type A), colloidal anhydrous silica, talc, magnesium stearate, dry essence of mixed fruits, aspartame (E 951), sodium lauryl sulfate.

Indications
Intestinal forms of helminthiasis and cutaneous syndrome Larva Migrans (short-term treatment with low doses): enterobiasis, hookworm and necatoriasis, hymenolepidosis, teniasis, strongyloidiasis, ascariasis, trichocephalosis, clonorchiasis, opisthorchiasis, giardiasis in children.

Systemic helminth infections (long-term treatment with high doses):

Cystic echinococcosis (caused by Echinococcus granulosus):

if surgical intervention is not possible;

before surgical intervention;

after surgery, if preoperative treatment was short, if helminths are widespread or live forms were found during surgery;

after percutaneous drainage of cysts for diagnostic or therapeutic purposes;

alveolar echinococcosis (caused by Echinococcus multiocularis):

in inoperable disease, in particular in cases of local or distant metastases;
after palliative surgery;
after radical surgery or liver transplantation;
neurocysticercosis (caused by Taenia solium larvae):
in the presence of single or multiple cysts or granulomatous brain lesions;
in arachnoid or intraventricular cysts;
in racemose cysts;
capillarosis (caused by Capillaria philippinensis), gnathostomiasis (caused by Gnathostoma spinigerum and related species), trichinosis (caused by Trichinella spiralis and T. pseudospiralis), toxocariasis (caused by Toxocara canis and related species).